
FLAVMOX 35MG TABLET MR
Marketer
Maxlive Pharmaceuticals Pvt Ltd
Salt Composition
Trimetazidine (35mg)
Overview FLAVMOX 35MG TABLET MR
Cardoxin 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest pain stemming from heart issues. This medication acts to prevent future angina episodes but won't alleviate an attack already in progress. It can be administered independently or alongside other cardiac medications. Always adhere to your physician's prescribed dosage and schedule for Cardoxin 35mg ER Tablets; consumption with or without food is acceptable, maintaining consistent timing. Dosage frequency may adjust based on treatment efficacy. Continuous use is crucial for optimal results, even during symptom-free periods, helping to safeguard against future cardiac events. Discontinuing treatment may lead to a recurrence of angina. Complementing medication with lifestyle adjustments – such as smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – can significantly improve cardiovascular health. Potential side effects include, but are not limited to, lightheadedness, cephalalgia, stomach upset, bowel irregularities, dyspepsia, queasiness, emesis, skin rashes, pruritus, urticaria, and asthenia. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your physician of any existing liver or kidney conditions, pregnancy, breastfeeding, or other concurrent medications.
Primary Ingredients of FLAVMOX 35MG TABLET MR
No text provided. Please provide the text you wish me to rephrase.
Uses of FLAVMOX 35MG TABLET MR
Managing chest pain associated with angina pectoris
Major Benefits of FLAVMOX 35MG TABLET MR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 35mg modified-release FLAVMOX tablet whole; avoid chewing, crushing, or fracturing it. Consume with food.
Common Side effects of FLAVMOX 35MG TABLET MR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use FLAVMOX 35MG TABLET MR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It is recommended to take the FLAVMOX 35MG TABLET MR with a meal.
How FLAVMOX 35MG TABLET MR works:
Cardiometabolic agent FLAVMOX 35MG MR tablets alleviate angina symptoms. This is achieved by altering myocardial metabolism, favoring glucose over fatty acids as fuel, thus enhancing cardiac efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of FLAVMOX 35MG TABLET MR and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on the use of FLAVMOX 35MG TABLET MR in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on FLAVMOX 35MG TABLET MR usage while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Taking FLAVMOX 35MG TABLET MR might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving is prohibited should these effects arise.
KidneyCAUTION
Exercise caution when administering 35 mg modified-release Flavmox tablets to individuals with impaired renal function. Dosage modification of 35 mg modified-release Flavmox tablets may be necessary. Physician consultation is advised. 35 mg modified-release Flavmox tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of FLAVMOX 35MG TABLET MR in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take FLAVMOX 35MG TABLET MR :
Should you forget a dose of FLAVMOX 35MG TABLET MR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About FLAVMOX 35MG TABLET MR
| Label | Value |
|---|---|
| Chemical Type | Benzylamines |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Fatty acid regulator and sodium channel inhibitor |
